Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Purchased by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management GmbH significantly increased its stake in Bioceres Crop Solutions by 77.5% during the first quarter, now owning 236,717 shares valued at approximately $1.08 million.
• Bioceres Crop Solutions reported a negative earnings per share of ($0.02), surpassing analysts' expectations of ($0.10), despite generating $59.60 million in revenue, which fell short of the $61.80 million forecast.
• Analysts have a consensus rating of "Moderate Buy" for Bioceres, with a revised price target set at $6.00 following Oppenheimer's recent downgrade.

Allianz Asset Management GmbH boosted its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 77.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 236,717 shares of the company's stock after buying an additional 103,337 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.38% of Bioceres Crop Solutions worth $1,081,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. JPMorgan Chase & Co. increased its stake in shares of Bioceres Crop Solutions by 17.0% in the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock valued at $640,000 after purchasing an additional 15,328 shares in the last quarter. Jump Financial LLC acquired a new stake in Bioceres Crop Solutions in the fourth quarter valued at approximately $72,000. Stifel Financial Corp increased its position in shares of Bioceres Crop Solutions by 51.9% in the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock valued at $377,000 after buying an additional 21,168 shares in the last quarter. Long Focus Capital Management LLC raised its stake in shares of Bioceres Crop Solutions by 130.7% during the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after buying an additional 421,931 shares during the period. Finally, Northern Trust Corp purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter valued at approximately $93,000. Institutional investors and hedge funds own 17.68% of the company's stock.

Bioceres Crop Solutions Price Performance

Shares of BIOX traded up $0.05 during trading hours on Friday, hitting $3.47. 129,333 shares of the stock were exchanged, compared to its average volume of 122,628. The stock's 50-day moving average price is $4.42 and its two-hundred day moving average price is $4.76. Bioceres Crop Solutions Corp. has a 12-month low of $3.30 and a 12-month high of $11.41. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. The company has a market cap of $217.60 million, a price-to-earnings ratio of -24.78, a price-to-earnings-growth ratio of 1.46 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.08. The business had revenue of $59.60 million during the quarter, compared to analyst estimates of $61.80 million. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.37%. Research analysts expect that Bioceres Crop Solutions Corp. will post -0.05 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently commented on BIOX shares. Wall Street Zen raised shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a report on Saturday, July 26th. Oppenheimer dropped their target price on shares of Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 15th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $8.38.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.